| PERIOD ENDING | 30-Sep-09 | 23-Jul-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,364,736 | 2,227,627 | 2,789,827 | 2,843,245 | | Cost of Revenue | 1,912,882 | 1,795,201 | 2,238,416 | 2,544,818 | | | Gross Profit | 451,854 | 432,426 | 551,411 | 298,427 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 204,578 | 210,135 | 186,946 | 16,236 | | Non Recurring | 4,426 | (3,762) | (664) | (997) | | Others | 72,318 | 71,249 | 72,126 | 64,498 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 173,778 | 154,804 | 293,003 | 218,690 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,491 | 16,008 | 6,724 | 4,169 | | Earnings Before Interest And Taxes | 209,077 | 185,000 | 320,949 | 249,486 | | Interest Expense | 72,689 | 73,392 | 77,961 | 81,067 | | Income Before Tax | 136,388 | 111,608 | 242,988 | 168,419 | | Income Tax Expense | 34,080 | 30,258 | 79,439 | 47,098 | | Minority Interest | (135,201) |
-
|
-
| (53,147) | | | | Net Income From Continuing Ops | 22,571 | 81,350 | 163,549 | 68,174 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,893) | 81,350 | 163,549 | 68,174 | | Preferred Stock And Other Adjustments | 80,935 | (39,671) | (41,264) |
-
| | | Net Income Applicable To Common Shares | $48,042 | $41,679 | $122,285 | $68,174 |
|
1.48% Nasdaq 
Income Statement
